WallStSmart
TNGX

Tango Therapeutics Inc

NASDAQ: TNGX · HEALTHCARE · BIOTECHNOLOGY

$20.98
-2.96% today

Updated 2026-05-01

Market cap
$3.18B
P/E ratio
P/S ratio
51.01x
EPS (TTM)
$-0.87
Dividend yield
52W range
$1 – $28
Volume
3.5M

WallStSmart proprietary scores

20
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+
5.0
Quality
C+
2.0
Profitability
F
6.0
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$23.90
+13.92%
12-Month target
Intrinsic (DCF)
$16.11
Margin of safety
+21.73%
1 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ 21.73% below intrinsic value
Risks
- Thin margins at -162.90%
- Negative free cash flow $-29.94M
- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$24.86M$36.53M$42.07M$62.38M$62.38M
Net income$-108.18M$-101.74M$-130.30M$-101.59M$-38.75M
EPS$-0.87
Free cash flow$-116.77M$-119.51M$-132.25M$-139.93M$-29.94M
Profit margin-435.14%-278.54%-309.73%-162.85%-162.90%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
TNGX$3.18B205.32.06.05.0+21.73%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-26.29%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Tango Therapeutics Inc trades at $20.98. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $62.38M. with profit margins at -162.90%. Our DCF model estimates intrinsic value at $16.11.

Frequently asked questions

What is Tango Therapeutics Inc's stock price?
Tango Therapeutics Inc (TNGX) trades at $20.98.
Is Tango Therapeutics Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $16.11.
What is the price target of Tango Therapeutics Inc (TNGX)?
The analyst target price is $23.90, representing +13.9% upside from the current price of $20.98.
What is the intrinsic value of Tango Therapeutics Inc (TNGX)?
Based on our DCF model, intrinsic value is $16.11, a +21.7% margin of safety versus $20.98.
What is Tango Therapeutics Inc's revenue?
TTM revenue is $62.38M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio51.01x
ROE-37.20%
Beta1.32
50D MA$19.13
200D MA$11.27
Shares out0.14B
Float0.07B
Short ratio
Avg volume3.5M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years